Devasis Chatterjee

5.4k total citations · 1 hit paper
44 papers, 3.0k citations indexed

About

Devasis Chatterjee is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Devasis Chatterjee has authored 44 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Molecular Biology, 18 papers in Oncology and 13 papers in Pathology and Forensic Medicine. Recurrent topics in Devasis Chatterjee's work include Cancer Mechanisms and Therapy (13 papers), Cell death mechanisms and regulation (12 papers) and Melanoma and MAPK Pathways (9 papers). Devasis Chatterjee is often cited by papers focused on Cancer Mechanisms and Therapy (13 papers), Cell death mechanisms and regulation (12 papers) and Melanoma and MAPK Pathways (9 papers). Devasis Chatterjee collaborates with scholars based in United States, Italy and Mexico. Devasis Chatterjee's co-authors include Y. Eugene Chin, Yingjie Guan, Zhenglong Yuan, Kam C. Yeung, Asok Mukhopadhyay, James H. Wyche, Bharat B. Aggarwal, Benjamin Bonavida, Carlos E. Bueso‐Ramos and Peter J. Quesenberry and has published in prestigious journals such as Science, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Devasis Chatterjee

44 papers receiving 2.9k citations

Hit Papers

Stat3 Dimerization Regulated by Reversible Acetylation of... 2005 2026 2012 2019 2005 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Devasis Chatterjee United States 20 2.2k 760 624 601 393 44 3.0k
F. H. Sarkar United States 29 1.7k 0.8× 1.0k 1.4× 349 0.6× 962 1.6× 275 0.7× 72 3.2k
Allard Kaptein Netherlands 20 1.1k 0.5× 478 0.6× 455 0.7× 340 0.6× 422 1.1× 39 2.3k
Elizabeth A. Conner United States 34 2.5k 1.1× 1.0k 1.4× 485 0.8× 927 1.5× 282 0.7× 46 4.4k
William H. Chappell United States 27 2.7k 1.2× 1.3k 1.7× 466 0.7× 695 1.2× 322 0.8× 41 4.0k
Ladislav Anděra Czechia 29 1.9k 0.9× 778 1.0× 190 0.3× 435 0.7× 358 0.9× 79 2.7k
Amro Aboukameel United States 31 2.0k 0.9× 1.0k 1.4× 226 0.4× 611 1.0× 219 0.6× 91 2.8k
Jörg Bäsecke Germany 22 3.0k 1.4× 1.2k 1.5× 460 0.7× 669 1.1× 395 1.0× 34 4.4k
In‐Chul Park South Korea 32 1.8k 0.8× 543 0.7× 149 0.2× 589 1.0× 228 0.6× 116 2.8k
Zhuo Zhang China 30 1.9k 0.9× 1.6k 2.1× 222 0.4× 785 1.3× 305 0.8× 99 3.5k
Pulicat Manogaran Saudi Arabia 19 875 0.4× 499 0.7× 276 0.4× 206 0.3× 295 0.8× 35 1.6k

Countries citing papers authored by Devasis Chatterjee

Since Specialization
Citations

This map shows the geographic impact of Devasis Chatterjee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Devasis Chatterjee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Devasis Chatterjee more than expected).

Fields of papers citing papers by Devasis Chatterjee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Devasis Chatterjee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Devasis Chatterjee. The network helps show where Devasis Chatterjee may publish in the future.

Co-authorship network of co-authors of Devasis Chatterjee

This figure shows the co-authorship network connecting the top 25 collaborators of Devasis Chatterjee. A scholar is included among the top collaborators of Devasis Chatterjee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Devasis Chatterjee. Devasis Chatterjee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Justin, Evan T. Keller, Atsushi Mizokami, et al.. (2015). Extracellular Vesicle-Mediated Reversal of Paclitaxel Resistance in Prostate Cancer. Critical Reviews™ in Oncogenesis. 20(5-6). 407–417. 14 indexed citations
2.
Mulvey, Hillary E., et al.. (2015). Extracellular vesicle-mediated phenotype switching in malignant and non-malignant colon cells. BMC Cancer. 15(1). 571–571. 28 indexed citations
3.
Wen, Sicheng, et al.. (2014). Role of Raf Kinase Inhibitor Protein in Helicobacter pylori-Mediated Signaling in Gastric Cancer. Critical Reviews™ in Oncogenesis. 19(6). 469–481. 12 indexed citations
4.
Pantazatos, Dennis, Michael Del Tatto, David Mills, et al.. (2013). Reversal of chemosensitivity and induction of cell malignancy of a non-malignant prostate cancer cell line upon extracellular vesicle exposure. Molecular Cancer. 12(1). 118–118. 36 indexed citations
5.
Das, Swadesh K., Sujit K. Bhutia, Upneet K. Sokhi, et al.. (2012). Raf Kinase Inhibitor RKIP Inhibits MDA-9/Syntenin-Mediated Metastasis in Melanoma. Cancer Research. 72(23). 6217–6226. 49 indexed citations
6.
Huerta‐Yépez, Sara, Nam K. Yoon, Vei Mah, et al.. (2011). Expression of phosphorylated raf kinase inhibitor protein (pRKIP) is a predictor of lung cancer survival. BMC Cancer. 11(1). 259–259. 30 indexed citations
7.
Bonavida, Benjamin, Stavroula Baritaki, Sara Huerta‐Yépez, et al.. (2008). Novel therapeutic applications of nitric oxide donors in cancer: Roles in chemo- and immunosensitization to apoptosis and inhibition of metastases. Nitric Oxide. 19(2). 152–157. 109 indexed citations
8.
Darnowski, James W., Yingjie Guan, Devasis Chatterjee, et al.. (2006). Stat3 Cleavage by Caspases. Journal of Biological Chemistry. 281(26). 17707–17717. 39 indexed citations
9.
Yuan, Zhenglong, Yingjie Guan, Devasis Chatterjee, & Y. Eugene Chin. (2005). Stat3 Dimerization Regulated by Reversible Acetylation of a Single Lysine Residue. Science. 307(5707). 269–273. 630 indexed citations breakdown →
10.
Hongo, Fumiya, Sara Huerta‐Yépez, Hong‐Jeng Yu, et al.. (2005). Overexpression of inhibitor of apoptosis protein XIAP in human prostate cancer. Cancer Research. 65. 993–993. 1 indexed citations
11.
Chatterjee, Devasis, et al.. (2004). Raf-1 Kinase Inhibitor Protein: Structure, Function, Regulation of Cell Signaling, and Pivotal Role in Apoptosis. Advances in cancer research. 91. 169–200. 155 indexed citations
12.
Chatterjee, Devasis, et al.. (2004). Mechanistic and antineoplastic evaluation of taurolidine in the DU145 model of human prostate cancer. Cancer Chemotherapy and Pharmacology. 54(3). 249–58. 30 indexed citations
13.
Pantazis, Panayotis, Devasis Chatterjee, Zhiyong Han, & James H. Wyche. (1999). Modulation of 9-nitrocamptothecin-induced apoptosis by hyperthermia in human leukemia HL-60 cells. Anti-Cancer Drugs. 10(3). 317–322. 1 indexed citations
14.
Pantazis, Panayotis, Zhiyong Han, Devasis Chatterjee, & James H. Wyche. (1999). Water-insoluble camptothecin analogues as potential antiviral drugs. Journal of Biomedical Science. 6(1). 1–7. 26 indexed citations
15.
Chatterjee, Devasis, et al.. (1999). Differentiation of Human Malignant Melanoma Cells that Escape Apoptosis After Treatment with 9-Nitrocamptothecin In Vitro. Neoplasia. 1(3). 231–240. 13 indexed citations
16.
Chatterjee, Devasis, James H. Wyche, & Panayotis Pantazis. (1996). Induction of Apoptosis in Malignant and Camptothecin‐resistant Human Cellsa. Annals of the New York Academy of Sciences. 803(1). 143–156. 11 indexed citations
17.
Chatterjee, Devasis, et al.. (1996). Monocytic differentiation and synthesis of proteins associated with apoptosis in human leukemia U‐937 cells acquiring resistance to Vincristine. European Journal Of Haematology. 57(1). 79–86. 3 indexed citations
18.
Chatterjee, Devasis, et al.. (1995). Molecular characterization of the in vivo alkylating agent resistant murine EMT-6 mammary carcinoma tumors. Cancer Chemotherapy and Pharmacology. 35(5). 423–431. 16 indexed citations
19.
Han, Zhiyong, Devasis Chatterjee, Anke Bakker, & James H. Wyche. (1994). Negative and positive regulation of IGF-II mRNA expression in cultured rat cells by chicken serum. Molecular and Cellular Endocrinology. 99(2). 293–300. 1 indexed citations
20.
Teicher, Beverly A., et al.. (1993). Protection of bone-marrow granulocyte-macrophage colony-forming units in mice bearing in vivo alkylating-agent-resistant EMT-6 tumors. Cancer Chemotherapy and Pharmacology. 32(4). 315–319. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026